Group 1 - Wuxi City held an innovation achievement exchange meeting focusing on "integration of production, medicine, and research" in healthcare, announcing 9 innovative results aimed at benefiting the public [1] - A new round of cooperation agreement was signed between Wuxi and the National Cancer Center to enhance cancer prevention actions, exploring seamless connections in early screening, diagnosis, and treatment to reduce medical costs and family financial burdens [1] - The "Yihui Xicheng" new product and "One-click e-compensation" feature will be launched in 2026, introducing innovative drug and device coverage and increasing DRG exclusions to further alleviate the medical burden on citizens [1] Group 2 - Wuxi announced the introduction of a new batch of medical expert teams and high-level healthcare talents, establishing a clinical trial institution alliance and releasing the first batch of biopharmaceutical innovation product catalog for 2025 [2] - The Wuxi Guolian Health Foundation was officially established with an initial fundraising of 30 million yuan for medical research, talent training, and support for disadvantaged groups [2] - Eight banks jointly launched a special loan product for biomedicine, providing a total credit limit of 16 billion yuan to the first batch of 16 enterprises [2] Group 3 - Wuxi has accelerated the high-quality development of "integration of production, medicine, and research" in healthcare, achieving a total of 3 first-class innovative drugs and 8 second and third-class innovative medical devices listed [2] - Over the past three years, Wuxi has supported 31 projects combining medicine and engineering, and has been recognized as one of the top 20 cities in China's biopharmaceutical industry development index for two consecutive years [2] - The biopharmaceutical cluster in Wuxi has been selected as a national advanced manufacturing cluster [2]

交流会上，无锡市药物临床试验机构联盟揭牌成立，2025年首批生物医药创新产品目录正式发布，无锡 新一代互联网医院同步上线。多位院士专家现场就医学科技创新前沿与成果转化应用作专题分享。 据悉，无锡已累计获批3个一类创新药、8个二类和三类创新医疗（002173）器械，近三年支持医工结合 项目31个，连续两年入选中国生物医药产业发展指数20强城市，生物医药集群获批国家先进制造业集 群。目前，该市正加快推进《无锡生物医药全产业链开放创新发展实施方案》和《无锡高新区生物医药 产业发展规划(2025-2030年)》编制工作。 由国联人寿主承保的2026年"医惠锡城"新产品暨"一键e赔"功能同步上线，推出创新药械纳入保障、增 加DRG除外责任等多项服务，进一步减轻群众就医负担。为进一步推动"创新药进医院、科研成果转 化"，无锡市国联健康基金会正式成立，首期募集资金3000万元。基金会现场向首批资助的市人民医院 胃癌早筛、江大附院核素药物转化两个科研项目进行捐赠。 中证报中证网讯(王珞)9月30日，无锡市医疗健康"产医研融合"创新成果交流会举行。现场，无锡市与 国家癌症中心签署新一轮深化合作协议，双方将共同深入开展全民癌症防 ...